WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received five awards at the 2025 Asia-Pacific ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...